Literature DB >> 117074

A role for clonal dominance in the maintenance of allotype suppression?

A Yamada, L T Adler, F L Adler.   

Abstract

The establishment of immunological memory during the early and complete phase of allotype suppression in the young rabbit has been shown to lead to the preferential production of antibodies with the nonsuppressed allotypic specificity in response to recall injections given after spontaneous or induced release from suppression. It is suggested that this manifestation of clonal dominance, applied to stimulation by environmental antigens, may contribute to the long lasting persistence of allotype imbalance in allotype suppressed rabbits.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 117074      PMCID: PMC2185668          DOI: 10.1084/jem.150.4.888

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

Review 1.  Regulation of immunoglobulin and antibody production by allotype suppressor T cells in mice.

Authors:  L A Herzenberg; K Okumura; C M Metzler
Journal:  Transplant Rev       Date:  1975

2.  Effect of maternal isoantibodies on the quantitative expression of two allelic genes controlling gamma-globulin allotypic specificities.

Authors:  S DRAY
Journal:  Nature       Date:  1962-08-18       Impact factor: 49.962

3.  Recovery from allotype suppression in rabbits and release from this suppression in specific immune response.

Authors:  A Seto; K J Mori; Y Ito
Journal:  Ann Immunol (Paris)       Date:  1975 Jun-Jul

4.  Dominance of a cell clone forming antibody to DNP.

Authors:  B A Askonas; A R Williamson
Journal:  Nature       Date:  1972-08-11       Impact factor: 49.962

5.  in vitro studies on allotype suppression. I. Release from allotype suppression by antibodies specific for the non-suppressed allotype.

Authors:  L T Adler
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  Humoral and cellular aspects of immunoglobulin allotype suppression in the rabbit. I. Kinetics of neutralization of suppression.

Authors:  J A Lowe; L M Cross; D Catty
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

7.  Enduring antibody responses in "normal" rabbits to maternal immunoglobulin allotypes.

Authors:  F L Adler; R J Noelle
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

8.  Neutralization of allotype suppression in rabbits.

Authors:  G O Young-Cooper; R G Mage
Journal:  Immunology       Date:  1974-04       Impact factor: 7.397

9.  Preferential assignment of allotype a1 globulin for the production of early IgM anti-para-azobenzenearsonate antibodies in heterozygous a1a3 rabbits.

Authors:  C C Chien; J S Ingraham
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

10.  Allotype suppression in the rabbit. I. The ontogeny of cells bearing immunoglobulin of paternal allotype and the fate of these cells after treatment with antiallotype antisera.

Authors:  M R Harrison; R G Mage
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  4 in total

1.  Expression of kappa chain allotypes at the cell surface and in serum immunoglobulins of normal and allotype-suppressed heterozygous rabbits.

Authors:  H B Abdi; M A Simons; G O Young-Cooper; R G Mage
Journal:  Immunology       Date:  1982-07       Impact factor: 7.397

2.  Cellular basis of an auto-anti-allotypic mechanism for the maintenance of chronic allotype suppression in the rabbit.

Authors:  L T Adler; E Claassen
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

3.  Physiology of IgD. I. Compensatory phenomena in B lymphocyte activation in mice treated with anti-IgD antibodies.

Authors:  E B Jacobson; Y Baine; Y W Chen; T Flotte; M J O'Neil; B Pernis; G W Siskind; G J Thorbecke; P Tonda
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

4.  Monoclonal antibody to an IgD allotype induces a new type of allotype suppression in the mouse.

Authors:  T Tokuhisa; F T Gadus; L A Herzenberg; L A Herzenberg
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.